menu
    • menu

    Company profile for BriaCell Therapeutics

    NEW Drugs in Dev: 6
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dedicated to enhance the lives of women who are facing limited breast cancer therapy options, BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V)’s mission has been to develop novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy the cancer cells, offering the potential for higher levels of safety and efficacy than c...
    Dedicated to enhance the lives of women who are facing limited breast cancer therapy options, BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V)’s mission has been to develop novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy the cancer cells, offering the potential for higher levels of safety and efficacy than chemotherapy and which may prevent cancer recurrence.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BriaCell TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 300 - Bellevue Centre, 235 -15th Street, West Vancouver, BC V7T 2X1
    Telephone
    Telephone
    +1604-921-1810
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://briacell.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BriaCell, BriaPro Sign CD80 Asset Purchase Deal
    BriaCell, BriaPro Sign CD80 Asset Purchase Deal

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240709/0/en/BriaCell-and-BriaPro-Enter-Into-Asset-Purchase-Agreement-for-Exclusive-Soluble-CD80-License.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    BriaCell Gets DSMB Backing for Ph3 Breast Cancer
    BriaCell Gets DSMB Backing for Ph3 Breast Cancer

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239128/0/en/BriaCell-Receives-Positive-Recommendation-from-Data-Safety-Monitoring-Board-DSMB-for-Phase-3-Study-in-Metastatic-Breast-Cancer.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Briacell Patients Demonstrate Tumor Regression, Immune Activation
    Briacell Patients Demonstrate Tumor Regression, Immune Activation

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227515/0/en/BriaCell-Patients-Images-Show-Regression-and-Resolution-of-Metastasized-Tumors-and-Immune-Activation.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    BriaCell: 18-47-Month Survival in Phase 2 Metastatic BC Trial
    BriaCell: 18-47-Month Survival in Phase 2 Metastatic BC Trial

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226377/0/en/BriaCell-Highlights-Extended-18-47-Months-Survival-in-Phase-2-Metastatic-Breast-Cancer-Patients.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Briacell Therapeutics Completes $30M Public Offering
    Briacell Therapeutics Completes $30M Public Offering

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219983/0/en/BriaCell-Therapeutics-Announces-Closing-of-US-30-million-Public-Offering.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    BriaCell Report Resolution of Lung Metastasis in Bria-OTS Patient
    BriaCell Report Resolution of Lung Metastasis in Bria-OTS Patient

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217681/0/en/BriaCell-Reports-Sustained-Complete-Resolution-of-Lung-Metastasis-in-Bria-OTS-Patient.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search